Vaxart shares are trading higher after B. Riley Securities upgraded the stock from Neutral to Buy and announced a $2 price target.
Portfolio Pulse from Benzinga Newsdesk
Vaxart's stock (VXRT) has seen an increase in trading after B. Riley Securities upgraded the stock from Neutral to Buy, setting a price target of $2.
January 31, 2024 | 5:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vaxart's stock received a positive upgrade from B. Riley Securities, changing from Neutral to Buy, with a new price target of $2.
Analyst upgrades typically lead to a positive short-term reaction in a stock's price as they suggest a better outlook for the company. The upgrade from Neutral to Buy indicates increased confidence in Vaxart's potential, and the $2 price target suggests a significant upside from current levels. This can attract investors and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100